N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline | |
---|---|
Trade Name | |
Orphan Indication | Hepatocellular Carcinoma |
USA Market Approval | USA |
USA Designation Date | 2017-06-14 00:00:00 |
Sponsor | MedPacto, Inc.;145 Gwanggyo-ro, Advanced Institutes of Convergence Technology;Suwon |